KCNIP3 (potassium channel interacting protein 3) functions as a multifunctional regulator with roles in ion channel modulation, transcriptional control, and disease pathogenesis. Structurally, KCNIP3 belongs to the neuronal calcium sensor superfamily and exists as a calcium-binding protein with alternative splice variants that contribute to functional diversity across tissues and brain regions 1. The protein modulates A-type potassium channels and favors their surface expression while functioning as a transcriptional repressor 12. KCNIP3 interacts with presenilin-2 to modulate amyloid-beta formation and apoptotic processes, linking it to Alzheimer's disease pathology 2. In cancer biology, KCNIP3 demonstrates tumor-suppressive properties in papillary thyroid carcinoma, where silencing promotes cell proliferation and epithelial-mesenchymal transition through Wnt/β-catenin pathway activation 3. Conversely, KCNIP3 overexpression inhibits cancer cell viability and induces apoptosis while suppressing EMT 3. In rheumatoid arthritis, KCNIP3 emerges as a key protective factor and mediates the relationship between polyomavirus immune responses and RA development 4. Additionally, KCNIP3 expression is regulated by homoarginine and creatine metabolism in the brain, suggesting involvement in neuronal excitability and stroke pathology 5. KCNIP3 was also elevated in ALS patients receiving riluzole treatment 6, indicating potential pharmacodynamic responsiveness.